Mangoceuticals Statistics Share Statistics Mangoceuticals has 10.54M
shares outstanding. The number of shares has increased by 323.72%
in one year.
Shares Outstanding 10.54M Shares Change (YoY) 323.72% Shares Change (QoQ) 6.59% Owned by Institutions (%) n/a Shares Floating 5.12M Failed to Deliver (FTD) Shares 13,654 FTD / Avg. Volume 8.6%
Short Selling Information The latest short interest is 270.06K, so 2.36% of the outstanding
shares have been sold short.
Short Interest 270.06K Short % of Shares Out 2.36% Short % of Float 2.81% Short Ratio (days to cover) 1.67
Valuation Ratios The PE ratio is -0.55 and the forward
PE ratio is null.
Mangoceuticals's PEG ratio is
0.01.
PE Ratio -0.55 Forward PE n/a PS Ratio 7.78 Forward PS n/a PB Ratio 0.34 P/FCF Ratio -0.98 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Mangoceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.05,
with a Debt / Equity ratio of 0.02.
Current Ratio 0.05 Quick Ratio 0.05 Debt / Equity 0.02 Debt / EBITDA -0.03 Debt / FCF -0.04 Interest Coverage -581.9
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $205.29K Profits Per Employee $-2.9M Employee Count 3 Asset Turnover 0.04 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -31% in the
last 52 weeks. The beta is 2.4, so Mangoceuticals's
price volatility has been higher than the market average.
Beta 2.4 52-Week Price Change -31% 50-Day Moving Average 1.98 200-Day Moving Average 2.43 Relative Strength Index (RSI) 54.04 Average Volume (20 Days) 158,766
Income Statement In the last 12 months, Mangoceuticals had revenue of 615.87K
and earned -8.71M
in profits. Earnings per share was -4.84.
Revenue 615.87K Gross Profit 379.96K Operating Income -7.97M Net Income -8.71M EBITDA -7.96M EBIT -8.69M Earnings Per Share (EPS) -4.84
Full Income Statement Balance Sheet The company has 58.65K in cash and 214.96K in
debt, giving a net cash position of -156.31K.
Cash & Cash Equivalents 58.65K Total Debt 214.96K Net Cash -156.31K Retained Earnings -20.81M Total Assets 20.84M Working Capital -1.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.86M
and capital expenditures 0, giving a free cash flow of -4.86M.
Operating Cash Flow -4.86M Capital Expenditures n/a Free Cash Flow -4.86M FCF Per Share -2.46
Full Cash Flow Statement Margins Gross margin is 61.7%, with operating and profit margins of -1294.42% and -1413.6%.
Gross Margin 61.7% Operating Margin -1294.42% Pretax Margin -1413.77% Profit Margin -1413.6% EBITDA Margin -1292.8% EBIT Margin -1294.42% FCF Margin -789.74%
Dividends & Yields MGRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for MGRX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 16, 2024. It was a
backward
split with a ratio of 1:15.
Last Split Date Oct 16, 2024 Split Type backward Split Ratio 1:15
Scores Altman Z-Score 5.62 Piotroski F-Score 2
